About Moderna

Moderna Therapeutics, operating under the ticker MRNA, is a biotechnology company focused on developing mRNA-based vaccines and therapeutics for infectious diseases, cancer, and rare genetic diseases. The company's pipeline includes its flagship COVID-19 vaccine, Spikevax, as well as candidates for influenza, HIV, and other conditions. By leveraging its innovative mRNA technology, Moderna aims to revolutionize the treatment and prevention of various diseases, transforming the future of medicine.